CN101180052B - 含有右旋糖的薄膜包衣制剂 - Google Patents

含有右旋糖的薄膜包衣制剂 Download PDF

Info

Publication number
CN101180052B
CN101180052B CN2006800175368A CN200680017536A CN101180052B CN 101180052 B CN101180052 B CN 101180052B CN 2006800175368 A CN2006800175368 A CN 2006800175368A CN 200680017536 A CN200680017536 A CN 200680017536A CN 101180052 B CN101180052 B CN 101180052B
Authority
CN
China
Prior art keywords
film
coated preparation
thin layer
coated
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN2006800175368A
Other languages
English (en)
Chinese (zh)
Other versions
CN101180052A (zh
Inventor
滨浦健司
长谷川晋
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of CN101180052A publication Critical patent/CN101180052A/zh
Application granted granted Critical
Publication of CN101180052B publication Critical patent/CN101180052B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN2006800175368A 2005-05-20 2006-05-19 含有右旋糖的薄膜包衣制剂 Active CN101180052B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP147435/2005 2005-05-20
JP2005147435 2005-05-20
PCT/JP2006/309994 WO2006123766A1 (fr) 2005-05-20 2006-05-19 Preparation recouverte d’un film contenant du dextrose

Publications (2)

Publication Number Publication Date
CN101180052A CN101180052A (zh) 2008-05-14
CN101180052B true CN101180052B (zh) 2010-11-17

Family

ID=37431334

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2006800175368A Active CN101180052B (zh) 2005-05-20 2006-05-19 含有右旋糖的薄膜包衣制剂

Country Status (5)

Country Link
JP (1) JP4979577B2 (fr)
KR (1) KR101314439B1 (fr)
CN (1) CN101180052B (fr)
TW (1) TWI367756B (fr)
WO (1) WO2006123766A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101400653B1 (ko) * 2006-10-25 2014-05-27 다이이찌 산쿄 가부시키가이샤 포장재
TW200833325A (en) * 2006-12-26 2008-08-16 Daiichi Sankyo Co Ltd Pharmaceutical composition comprising ascorbic acid
TWI414310B (zh) * 2006-12-26 2013-11-11 Daiichi Sankyo Co Ltd 溶出性改善之醫藥品組成物
JP2008201711A (ja) * 2007-02-20 2008-09-04 Ss Pharmaceut Co Ltd システイン臭が低減された固形製剤
KR20100072317A (ko) * 2007-10-29 2010-06-30 다이이찌 산쿄 가부시키가이샤 필름 코팅 제제
JP5688799B2 (ja) * 2008-08-11 2015-03-25 第一三共株式会社 におい抑制方法
JP4803686B2 (ja) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
CN102716100B (zh) * 2012-07-12 2013-08-07 南京正大天晴制药有限公司 一种含奥美沙坦酯的片剂及其制备方法
JP6360007B2 (ja) * 2015-06-12 2018-07-18 富士フイルム株式会社 薬物含有粒子の製造方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049270A2 (fr) * 1999-12-30 2001-07-12 Ancile Pharmaceuticals, Inc. Enrobage masquant les odeurs pour preparation pharmaceutique
EP1336407A1 (fr) * 2000-11-21 2003-08-20 Sankyo Company, Limited Compositions medicinales

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4107831B2 (ja) * 2000-11-21 2008-06-25 第一三共株式会社 医薬組成物
JP4647851B2 (ja) * 2001-08-07 2011-03-09 日立マクセル株式会社 カメラモジュール
AU2004208615C1 (en) * 2003-01-31 2010-05-13 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001049270A2 (fr) * 1999-12-30 2001-07-12 Ancile Pharmaceuticals, Inc. Enrobage masquant les odeurs pour preparation pharmaceutique
EP1336407A1 (fr) * 2000-11-21 2003-08-20 Sankyo Company, Limited Compositions medicinales

Also Published As

Publication number Publication date
KR20080008362A (ko) 2008-01-23
TWI367756B (en) 2012-07-11
JPWO2006123766A1 (ja) 2008-12-25
WO2006123766A1 (fr) 2006-11-23
JP4979577B2 (ja) 2012-07-18
CN101180052A (zh) 2008-05-14
KR101314439B1 (ko) 2013-10-07
TW200719888A (en) 2007-06-01

Similar Documents

Publication Publication Date Title
CN101171006B (zh) 薄膜包衣制剂
CN101180052B (zh) 含有右旋糖的薄膜包衣制剂
CN101842096A (zh) 薄膜包衣制剂
KR101114808B1 (ko) 피복 제제의 제조법
CN104220068B (zh) 包含奥美沙坦酯和罗苏伐他汀或其盐的药物组合物
TW200803860A (en) Stable pharmaceutical composition comprising a pyrimidine-sulfamide
CN101212986B (zh) 稳定的乳化组合物
ES2569553T3 (es) Cápsula para la prevención de enfermedades cardiovasculares
JP5854571B2 (ja) におい抑制方法
MXPA02004389A (es) Composiciones farmaceuticas.
RU2491058C2 (ru) Галеновый состав алискирена и гидрохлортиазида
TWI535463B (zh) 醫藥固形製劑用之包衣劑、醫藥用膜衣製劑及被覆醫藥固形製劑
CN104602678A (zh) 包含厄贝沙坦和hmg-coa还原酶抑制剂的药物复合胶囊制剂
CN105682642A (zh) 雷诺嗪和决奈达隆的药物组合物
JPH11147819A (ja) 安定化された医薬製剤
KR101670693B1 (ko) 변색 및 냄새가 억제된 필름 코팅정
CN100496606C (zh) 含有硝酸酯类药物和HMG-CoA还原酶抑制剂的组合物制剂
US20130259935A1 (en) Pharmaceutical compositions comprising glimepiride and polyethylene glycol castor oil
CN109475557A (zh) 含有甲氨蝶呤的薄膜包衣片
CN102361635B (zh) 包衣固体制剂
WO2024084496A1 (fr) Compositions pharmaceutiques comprenant du maléate d'acalabrutinib
WO2019030610A1 (fr) Compositions pharmaceutiques à libération de médicament double directement compressibles
CN106176724A (zh) 一种稳定的固体药物组合物及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant